Role of adjuvant chemotherapy after pneumonectomy for non-small cell lung cancer

Wang,Meng; Zhao,Jing; Su,Yan-Jun; Zhao,Xiao-Liang; Wang,Chang-Li

doi:10.3892/ol.2012.892

December 2012 Volume 4 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

December 2012 Volume 4 Issue 6

Full Size Image

Article

Role of adjuvant chemotherapy after pneumonectomy for non-small cell lung cancer

Authors:
- Meng Wang
- Jing Zhao
- Yan-Jun Su
- Xiao-Liang Zhao
- Chang-Li Wang
View Affiliations / Copyright

Affiliations: Department of Lung Cancer, Cancer Institute and Hospital, Tianjin Medical University, Key Laboratory of Cancer Prevention and Therapy Tianjin, Tianjin 300060, P.R. China, Department of Breast Cancer, Cancer Institute and Hospital, Tianjin Medical University, Tianjin 300060, P.R. China
Pages: 1349-1353
|
Published online on: September 3, 2012

https://doi.org/10.3892/ol.2012.892
Expand metrics +

Abstract

Adjuvant chemotherapy is used as an alternative treatment for non-small cell lung cancer (NSCLC); however, the efficiency of post-pneumonectomy adjuvant chemotherapy in NSCLC has not been clarified. In the present study, patients who benefited from adjuvant chemotherapy with TP/NP/GP were identified. A total of 217 patients who underwent pneumonectomy were identified in this study. Of these, 87 underwent pneumonectomy combined with adjuvant chemotherapy (TP/NP/GP regimen) and 130 underwent pneumonectomy only in the initial management. The primary endpoint of the present study was overall survival. Actuarial survival analysis was conducted using the Kaplan-Meier method. Postoperative adjuvant chemotherapy significantly improved the survival rate of patients who underwent left pneumonectomy and in patients with a preoperative forced expiratory volume in 1 sec (FEV1) greater than or equal to 2 l. Age had no effect on the survival rate of patients with or without postoperative adjuvant therapy. Post-pneumonectomy adjuvant chemotherapy is an efficient therapy in NSCLC for patients with preoperative FEV1 greater than or equal to 2 l or who received left pneumonectomy.

View Figures

View References

1.	A NiiranenS Niitamo-KorhonenM KouriA AssendelftK MattsonS PyrhönenAdjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized studyJ Clin Oncol101927193219921333518
2.	H WadaS HitomiT TeramatsuAdjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer SurgeryJ Clin Oncol14104810541996
3.	H KatoM TsuboiM OhtaE HataN TsubotaN HamajimaA randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I (T1N0M0, T2N0M0) adenocarcinoma of the lungProc Am Soc Clin Oncol22abstract 2498200315598942
4.	R ArriagadaB BergmanA DunantT Le ChevalierJP PignonJ VansteenkisteInternational Adjuvant Lung Cancer Trial Collaborative GroupCisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancerN Engl J Med350351360200410.1056/NEJMoa03164414736927
5.	JR RobertsC EustisR DevoreD CarboneH ChoyD JohnsonInduction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancerAnn Thorac Surg72885888200110.1016/S0003-4975(01)02836-3
6.	N NovoaG VarelaMF JimenezMorbidity after surgery for non-small cell lung carcinoma is not related to neoadjuvant chemotherapyEur J Cardiothorac Surg20700704200110.1016/S1010-7940(01)00876-4
7.	CF MountainValue of the new TNM staging system for lung cancerChest961 Suppl47S49S198910.1378/chest.96.1_Supplement.47S2544360
8.	CF MountainRevisions in the International System for Staging Lung CancerChest11117101717199710.1378/chest.111.6.17109187198
9.	J WangJ OlakRE UltmannMK FergusonAssessment of pulmonary complications after lung resectionAnn Thorac Surg6714441447199910.1016/S0003-4975(99)00255-610355428
10.	British Thoracic SocietySociety of Cardiothoracic Surgeons of Great Britain and Ireland Working PartyBTS guidelines: guidelines on the selection of patients with lung cancer for surgeryThorax5689108200110.1136/thorax.56.2.8911209097
11.	AM NugentIC SteeleAM CarragherK McManusJA McGuiganJR GibbonsEffect of thoracotomy and lung resection on exercise capacity in patients with lung cancerThorax54334338199910.1136/thx.54.4.33410092695
12.	KR LarsenUG SvendsenN MilmanJ BrenøeB PetersenCardiopulmonary function at rest and during exercise after resection for bronchial carcinomaAnn Thorac Surg64960964199710.1016/S0003-4975(97)00635-89354509
13.	DE StoverRJ KanerAdverse effects of treatment: pulmonary toxicityCancer Principles & Practice of OncologyVT De VitaS HellmanAA Rosenberg7th editionLippincott Williams & WillkinsPhiladelphia253925452004
14.	L ChapR ShpinerM LevineL NortonM LillJ GlaspyPulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatmentBone Marrow Transplant2010631067199710.1038/sj.bmt.17010289466279
15.	T WintonR LivingstonD JohnsonJ RigasM JohnstonC ButtsNational Cancer Institute of Canada Clinical Trials GroupNational Cancer Institute of the United States Intergroup JBR.10 Trial InvestigatorsVinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancerN Engl J Med35225892597200510.1056/NEJMoa043623
16.	J MartinRJ GinsbergA AbolhodaMS BainsRJ DowneyRJ KorstMorbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomyAnn Thorac Surg7211491154200110.1016/S0003-4975(01)02995-211603428
17.	C DoddoliF BarlesiD TrousseS RobitailS YenaP AstoulOne hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefitsJ Thorac Cardiovasc Surg130416425200510.1016/j.jtcvs.2004.11.022

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Role of adjuvant chemotherapy after pneumonectomy for non-small cell lung cancer

This article is mentioned in:

Abstract

Figure 1

Figure 2

Related Articles